Coherus Biosciences Inc (CHRS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

As of close of business last night, Coherus Biosciences Inc’s stock clocked out at $1.74, up 2.96% from its previous closing price of $1.69. In other words, the price has increased by $2.96 from its previous closing price. On the day, 1.3 million shares were traded. CHRS stock price reached its highest trading level at $1.75 during the session, while it also had its lowest trading level at $1.61.


To gain a deeper understanding of CHRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.05 and its Current Ratio is at 1.17.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on November 17, 2023, initiated with a Outperform rating and assigned the stock a target price of $11.

On July 24, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $12.Citigroup initiated its Buy rating on July 24, 2023, with a $12 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 22 ’23 when Lanfear Dennis M sold 223,100 shares for $2.02 per share. The transaction valued at 449,770 led to the insider holds 731,693 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 199623248 and an Enterprise Value of 421010784. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66. Its current Enterprise Value per Revenue stands at 1.395 whereas that against EBITDA is -2.688.

Stock Price History:

Over the past 52 weeks, CHRS has reached a high of $5.63, while it has fallen to a 52-week low of $1.43. The 50-Day Moving Average of the stock is -17.58%, while the 200-Day Moving Average is calculated to be -36.52%.

Shares Statistics:

It appears that CHRS traded 2.01M shares on average per day over the past three months and 1289690 shares per day over the past ten days. A total of 112.22M shares are outstanding, with a floating share count of 109.47M. Insiders hold about 4.58% of the company’s shares, while institutions hold 70.00% stake in the company. Shares short for CHRS as of 1715731200 were 21784831 with a Short Ratio of 10.83, compared to 1713139200 on 21533726. Therefore, it implies a Short% of Shares Outstanding of 21784831 and a Short% of Float of 22.17.

Most Popular